|本期目录/Table of Contents|

[1]刘梦昭,刘长山.粉尘螨滴剂舌下免疫治疗哮喘伴过敏性鼻炎患儿的临床疗效及安全性[J].天津医科大学学报,2018,24(04):344-347.
 LIU Meng-zhao,LIU Chang-shan.Efficacy and safety of sublingual immunotherapy with dermatophagoides farinae drops for children with allergic rhinitis and asthma[J].Journal of Tianjin Medical University,2018,24(04):344-347.
点击复制

粉尘螨滴剂舌下免疫治疗哮喘伴过敏性鼻炎患儿的临床疗效及安全性(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
24卷
期数:
2018年04期
页码:
344-347
栏目:
出版日期:
2018-07-20

文章信息/Info

Title:
Efficacy and safety of sublingual immunotherapy with dermatophagoides farinae drops for children with allergic rhinitis and asthma
作者:
刘梦昭刘长山
天津医科大学第二医院儿科,天津 300211
Author(s):
LIU Meng-zhao LIU Chang-shan
Department of Pediatrics, The Second Hospital, Tianjin Medical University, Tianjin 300211, China
关键词:
哮喘舌下免疫治疗粉尘螨滴剂儿童
Keywords:
bronchial asthma sublingual immunotherapy(SLIT) dermatophagoides farinae children
分类号:
R725.6
DOI:
-
文献标志码:
摘要:
目的:观察粉尘螨滴剂舌下免疫治疗哮喘伴过敏性鼻炎患儿的临床疗效及安全性。方法:观察分析接受粉尘螨滴剂舌下免疫治疗的哮喘伴过敏性鼻炎患儿72例,根据免疫治疗疗程分为1年组、2年组、3年组,随访评估治疗前后患儿哮喘症状(日间和夜间症状)评分、鼻炎症状评分、总症状评分(哮喘和鼻炎症状评分总和)、药物使用评分、哮喘和鼻炎的视觉模拟评分(VAS评分)。结果:1年组、2年组和3年组患儿治疗后哮喘症状评分、鼻炎症状评分、总症状评分、药物使用评分、哮喘和鼻炎的VAS评分较治疗前均显著下降(P<0.05),治疗3年组和2年组药物使用评分显著低于1年组(P<0.05),2年组和3年组之间药物使用评分未见显著差异。各治疗组未发现不良反应。结论:粉尘螨滴剂舌下免疫不同治疗组均具有较好的临床疗效且安全性好,治疗2年以上的患儿临床疗效更好。
Abstract:
Objective: To evaluate the efficacy and safety of sublingual immunotherapy (SLIT) with dermatophagoides farinae drops in children with allergic rhinitis and asthma. Methods: Seventy-two children with asthma and allergic rhinitis who recieved dermatophagoides farinae drops were assigned into 1-year group, 2-year group and 3-year group according to the course of SLIT. The asthma symptom scores (ASS, day and night), rhinitis symptom scores (RSS), total symptom scores (TSS, asthma and rhinitis symptom scores),medication scores (MS), and VAS scores of asthma and rhinitis were evaluated before and after SLIT. Results: There were significant differences in ASS, RSS, TSS, MS and VAS scores among children who underwent SLIT compared with baseline(P<0.05). MS in 3-year group and 2-year group was significantly lower than that in 1-year group (P < 0.05). There were no significant differences in MS between 3-year group and 2-year group. Adverse reaction was not observed in each group. Conclusion: SLIT with dermatophagoides farinae drops is safe and effective in each SLIT group and has shown better efficacy after 2-year SLIT.

参考文献/References:


[1] 中华医学会儿科学会呼吸学组, 编辑委员会中华儿科杂志. 儿童支气管哮喘诊断与防治指南[J]. 中华儿科杂志, 2008,46(10):745
[2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 小儿学组中华医学会耳鼻咽喉头颈外科学分会鼻科学组, 中华儿科杂志编辑委员会. 儿童变应性鼻炎诊断和治疗指南(2010年,重庆)[J]. 中华耳鼻咽喉头颈外科杂志, 2011,46(1):7
[3] 曹兰芳, 陆权, 顾洪亮, 等. 舌下含服粉尘螨滴剂治疗儿童过敏性哮喘和变应性鼻炎的临床评价[J]. 中华儿科杂志, 2007,45(10):736
[4] Karakoc-Aydiner E, Eifan A O, Baris S, et al. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial[J]. J Investig Allergol Clin Immunol, 2015,25(5):334
[5] 中华医学会儿科学分会呼吸学组, 编辑委员会中华儿科杂志. 儿童支气管哮喘诊断与防治指南(2016年版)[J]. 中华儿科杂志, 2016,54(3):167
[6] 刘长山,王峥,阮小玲,等. 近年天津市区儿童哮喘的流行病学特点探讨[J]. 天津医药, 2002(3):176
[7] 王雪艳, 刘长山, 王峥, 等. 天津市城区0~14岁儿童支气管哮喘流行病学特点[J]. 中华实用儿科临床杂志, 2014,29(4):279
[8] Brunton S, Nelson H S, Bernstein D I, et al. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma[J]. Postgrad Med, 2017, 129(6):581
[9] Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy[J]. J Allergy Clin Immunol, 2015,136(3):556
[10] Canonica G W, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update[J]. World Allergy Organ J, 2014,7(1):6
[11] The Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. 2017. Available from www.ginasthma.org. [EB/OL]
[12] 杨珍, 陈同辛. 儿童不同过敏性疾病的过敏原构成分析[J]. 中国当代儿科杂志, 2015(9):912
[13] Novakova S M, Staevska M T, Novakova P I, et al. Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life[J]. Health Qual Life Outcomes, 2017, 15(1):189
[14] Calamita Z, Saconato H, Pela A B, et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method[J]. Allergy, 2006,61(10):1162
[15] Rodriguez D R P, Vidal C, Just J, et al. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment[J]. Pediatr Allergy Immunol, 2017,28(1):60
[16] Moral A, Moreno V, Giron F, et al. Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy[J]. J Asthma Allergy, 2016,9:129
[17] Stelmach I, Sobocinska A, Majak P, et al. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy[J]. Ann Allergy Asthma Immunol, 2012,109(4):274
[18] Eifan A O, Akkoc T, Yildiz A, et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial[J]. Clin Exp Allergy, 2010,40(6):922

相似文献/References:

[1]马利锋,刘长山,王雪艳,等.呼出气一氧化氮测定在儿童哮喘控制评估中的价值[J].天津医科大学学报,2013,19(05):407.
[2]杨晓丽,蒋 萍.超重对哮喘患者肺功能及呼出气一氧化氮的影响[J].天津医科大学学报,2013,19(06):493.
 YANG Xiao-li,JIANG Ping.Effect of overweight on lung function and fractional exhaled nitricoxide of asthma patients[J].Journal of Tianjin Medical University,2013,19(04):493.
[3]周秋梅,刘长山.中短程低剂量吸入糖皮质激素对哮喘儿童生长的影响[J].天津医科大学学报,2016,22(04):322.
 ZHOU Qiu-mei,LIU Chang-shan.Efficacy of short-medium term and low dose inhalation of corticosteroids in treatment of asthma and its effect on growth in children[J].Journal of Tianjin Medical University,2016,22(04):322.
[4]熊蕾蕾,张松林,张向峰,等.R848对哮喘患儿外周血中IFN-γ、IL-33和IgE表达的影响及临床意义[J].天津医科大学学报,2021,27(06):623.
 XIONG Lei-lei,ZHANG Song-lin,ZHANG Xiang-feng,et al.The effect of R848 on the expression of IFN-γ, IL-33 and IgE in the peripheral blood of children with asthma and its clinical significance[J].Journal of Tianjin Medical University,2021,27(04):623.
[5]李昱剑,阚璇.哮喘中miRNA、lncRNA、circRNA、转录因子和靶基因的调控网络[J].天津医科大学学报,2023,29(03):235.
 LI Yu-jian,KAN Xuan.Regulatory networks of miRNA,lncRNA,circRNA,transcription factors and target genes in asthma[J].Journal of Tianjin Medical University,2023,29(04):235.
[6]茹仙古丽·吾买尔,索睿 综述,赵晓赟 审校.数字疗法在哮喘疾病管理中的应用[J].天津医科大学学报,2023,29(03):344.
[7]索睿,郝天旭,茹仙古丽·吾买尔 综述,等.间充质干细胞来源的外泌体治疗哮喘的研究进展[J].天津医科大学学报,2023,29(06):673.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2018-07-20